Catalyst Wire Dossier Catalyst Wire Dossier

PEG-rhGH Injection

pegylated recombinant human growth hormone · Changchun GeneScience Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PEG-rhGH Injection, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics [Phase 2]

See pricing